Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells for its Revio HiFi sequencing ...
Amazon's Deals of the Day are all still here to make sure you get top tech for less, but the clock is ticking. Last chance to ...
The U.S. projected peak demand could reach 900 GW by 2030, with VPPs potentially serving up to 20% of peak load, reducing ...
Courts in Los Angeles and Riverside counties are testing an artificial intelligence tool and deciding whether it can be used ...
In an interview, Dr Amith Singhee, the director of IBM Research in India, said quantum advantage in at least one problem area ...